Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,783,676
+$657,239 QoQ
Shares Held
19,010
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#1,340
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $25,620,221 across 16 Drug Manufacturers - General names. ABBV ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,837 | $5,545,942 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
19,010 | $4,783,676 | |
| 3 | LLY |
ELI LILLY & Co
|
3,909 | $4,688,572 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,199 | $4,651,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,282 | $1,678,047 | |
| 6 | AMGN |
Amgen Inc
|
4,076 | $1,476,001 | |
| 7 | PFE |
Pfizer Inc
|
33,216 | $799,841 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,165 | $758,567 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,783,676 | 19,010 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,126,437 | 18,973 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,339,025 | 18,990 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,627,095 | 19,984 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,063,036 | 21,889 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,592,887 | 21,921 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $3,909,933 | 22,003 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $4,393,535 | 22,248 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,770,181 | 21,981 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,016,215 | 22,055 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,027,648 | 19,537 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,014,738 | 20,225 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,731,516 | 20,274 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,735,632 | 23,440 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,446,171 | 21,324 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,990,736 | 14,833 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,154,654 | 14,068 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,291,100 | 14,133 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,913,608 | 14,133 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,492,165 | 13,833 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,419,827 | 12,605 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,275,697 | 11,788 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,271,763 | 11,869 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,035,226 | 11,819 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,485,070 | 15,126 | Shares | Sole | 2020-09-28 | |
| 2020-03-31 | $1,097,059 | 14,399 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||